NORTHVALE, N.J.--(BUSINESS WIRE)--Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technologies, today announced that it has received approval for the listing of its common stock on the NASDAQ Capital Market and intends to withdraw its common stock from listing on the American Stock Exchange. Ivivi anticipates that trading of its common stock on the NASDAQ Capital Market will begin on January 2, 2008 under the symbol NASDAQ: IVVI. Ivivi also expects that the trading of its common stock on the American Stock Exchange will cease at the close of business on December 31, 2007.
